EFFECT OF DAPAGLIFLOZIN ON WORSENING HEART FAILURE AND CARDIOVASCULAR DEATH IN PATIENTS WITH HEART FAILURE WITH AND WITHOUT DIABETES ArticlePetrie M.C., Docherty K.F., Jhund P.S., Mcmurray J.J.V., Verma S., Inzucchi S.E., Anand I., Bělohlávek J., Böhm M., Chiang C.E., Chopra V.K., De Boer R.A., Desai A.S., Sabatine M.S., Solomon S.D., Diez M., Drozdz J., Dukát A., Ge J., Howlett J. ...JAMA. Том 323. 2020. С. 1353-1368
